Cingulate Joins Russell 3000E Index
Cingulate Inc. (NASDAQ: CING ), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has been added to the Russell 3000E® Index.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.